申请人:Chugai Seiyaku
Kabushiki Kaisha
公开号:EP0903346A1
公开(公告)日:1999-03-24
Compounds represented by the following general formula (1) or pharmaceutically acceptable salts thereof:
[wherein Z represents -A-X-R1, a heterocycle or cycloalkyl; A represents a methylene group; X represents a sulfur atom; R1 represents a benzoyl group; R2 represents - N(R3)R4 (wherein R3 represents a methyl group; and R4 represents an optionally substituted alkyl group, etc.); or a group represented by the following general formula (2):
wherein R5 and R6 represent each a hydrogen atom; and Y represents a group represented by the following general formula (3):
(wherein R4 is as defined above)}].
Because of having vasodilative effect, myocardial protective effect, antiplatelet aggregation effect, etc., the compounds represented by the above general formula (1) or pharmaceutically acceptable salts thereof are useful as drugs such as therapeutic medicines for angina pectoris.
由以下通式(1)代表的化合物或其药学上可接受的盐类:
[其中 Z 代表-A-X-R1、杂环或环烷基;A 代表亚甲基;X 代表硫原子;R1 代表苯甲酰基;R2 代表-N(R3)R4(其中 R3 代表甲基;R4 代表任选取代的烷基等);或下 列通式(2)所代表的基团:
其中 R5 和 R6 各代表一个氢原子;Y 代表由下式通式 (3) 所代表的基团:
(其中 R4 如上定义)}]。
由于具有血管扩张作用、心肌保护作用、抗血小板聚集作用等,上述通式(1)所代表的化合物或其药学上可接受的盐类可用作药物,如心绞痛的治疗药物。